Injectable bioactive poly(propylene fumarate) and polycaprolactone based click chemistry bone cement for spinal fusion in rabbits
Journal of Biomedical Materials Research Part A · 2024
DOI: 10.1002/jbm.a.37725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Xifeng Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Click Chemistry, Spinal Fusion, Bone Cements, Bone Morphogenetic Protein 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Degenerative spinal pathology is a widespread medical issue, and spine fusion surgeries are frequently performed. In this study, we fabricated an injectable bioactive click chemistry polymer cement for use in spinal fusion and bone regrowth. Taking advantages of the bioorthogonal click reaction, this cement can be crosslinked by itself eliminating the addition of a toxic initiator or catalyst, nor any external energy sources like UV light or heat. Furthermore, nano‐hydroxyapatite (nHA) and microspheres carrying recombinant human bone morphogenetic protein‐2 (rhBMP‐2) and recombinant human vascular endothelial growth factor (rhVEGF) were used to make the cement bioactive for vascular induction and osteointegration. After implantation into a rabbit posterolateral spinal fusion (PLF) model, the cement showed excellent induction of new bone formation and bridging bone, achieving results comparable to autograft control. This is largely due to the osteogenic properties of nano‐hydroxyapatite (nHA) and the released rhBMP‐2 and rhVEGF growth factors. Since the availability of autograft sources is limited in clinical settings, this injectable bioactive click chemistry cement may be a promising alternative for spine fusion applications in addressing various spinal conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Xifeng Liu
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Liu, X., Astudillo Potes, M. D., Serdiuk, V., Dashtdar, B., Schreiber, A. C., Rezaei, A., Lee Miller, A., Hamouda, A. M., Shafi, M., Elder, B. D., & Lu, L. (2024). Injectable bioactive poly(propylene fumarate) and polycaprolactone based click chemistry bone cement for spinal fusion in rabbits. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37725
Vancouver
Liu X, Astudillo Potes MD, Serdiuk V, Dashtdar B, Schreiber AC, Rezaei A, et al. Injectable bioactive poly(propylene fumarate) and polycaprolactone based click chemistry bone cement for spinal fusion in rabbits. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37725
BibTeX
@article{Liu2024,
author = {Liu, Xifeng and Astudillo Potes, Maria D and Serdiuk, Vitalii and Dashtdar, Babak and Schreiber, Areonna C and Rezaei, Asghar and Lee Miller, A and Hamouda, Abdelrahman M and Shafi, Mahnoor and Elder, Benjamin D and Lu, Lichun},
title = {Injectable bioactive poly(propylene fumarate) and polycaprolactone based click chemistry bone cement for spinal fusion in rabbits},
journal = {Journal of Biomedical Materials Research Part A},
year = {2024},
doi = {10.1002/jbm.a.37725}
}
EUVIMED